|
2022
|
Invention
|
Use of a proteasome inhibitor for the treatment of central nervous system (cns) cancers.
The pre... |
|
|
Invention
|
Compositions and methods for treating neoplastic diseases.
Disclosed herein are compositions and... |
|
2021
|
Invention
|
Morphic forms of marizomib and uses thereof.
The present invention relates to polymorphic forms ... |
|
2020
|
Invention
|
Use of marizomib for the treatment of central nervous system (cns) cancers. The present disclosur... |
|
|
Invention
|
Process of preparing (1r, 4r, 5s)-4-(2-chloroethyl)-1-((s)-((s)-cyclohex-2-en-1-yl)(hydroxy)methy... |
|
|
Invention
|
Salt formulations for the fermentation of marine microorganisms.
Growth medium are disclosed for... |
|
|
Invention
|
Morphic forms of marizomib and uses thereof. The present invention relates to polymorphic forms o... |
|
|
Invention
|
Sphingosine 1 phosphate receptor modulator. A compound is provided having following structure Com... |
|
|
Invention
|
Sphingosine 1 phosphate receptor modulators. Compounds are provided having the structure of Formu... |
|
2019
|
Invention
|
Methods and compositions of isoindoline-1,3-dione and isoindole prodrugs useful for treating canc... |
|
2018
|
Invention
|
Salt formulations for the fermentation of marine microorganisms. 12 at specified concentrations. ... |
|
|
Invention
|
Sphingosine 1 phosphate receptor agonists for neuroprotection. Methods of treating conditions for... |
|
|
Invention
|
Novel glp-1 receptor modulators. Compounds are provided that modulate the glucagon-like peptide 1... |
|
|
Invention
|
Use of a proteasome inhibitor for the treatment of central nervous system (cns) cancers. The pres... |
|
2017
|
Invention
|
Dimethylaminoethanol salt of a glp-1 receptor modulator. Crystalline 2-hydroxy-N,N-dimethylethana... |
|
|
Invention
|
Compounds and methods for treating lupus. Methods for treatment of systemic lupus erythematosus (... |
|
|
Invention
|
Cxcr3 receptor agonists. Compounds are provided having the structure of the following Formula I: ... |
|
2016
|
Invention
|
Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of c... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of
leukemia, auto inflammatory disease, aut... |
|
2015
|
Invention
|
Glp-1 receptor modulators. Compounds are provided that modulate the glucagon-like peptide 1 (GLP-... |
|
2014
|
Invention
|
Selective sphingosine 1 phosphate receptor modulators and combination therapy therewith. Compound... |
|
|
Invention
|
Compositions and methods for treating neoplastic diseases. Disclosed herein are compositions and ... |
|
2008
|
Invention
|
Methods of using [3.2.0] heterocyclic compounds and analogs thereof. Disclosed are methods of tre... |
|
2004
|
Invention
|
Methods of using [3.2.0] heterocyclic compounds and analogs thereof.
Disclosed are methods of tr... |
